Search

Your search keyword '"Kuzel, Timothy M."' showing total 21 results

Search Constraints

Start Over You searched for: Author "Kuzel, Timothy M." Remove constraint Author: "Kuzel, Timothy M." Topic carcinoma, renal cell Remove constraint Topic: carcinoma, renal cell
21 results on '"Kuzel, Timothy M."'

Search Results

1. Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.

2. FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy.

3. A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma.

4. The Efficacy of Lenvatinib and Everolimus in Chromophobe-type Non-Clear-Cell Renal Cell Carcinoma: A Case Report and Literature Review.

5. Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial.

8. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.

9. Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial.

10. Kidney cancer, version 3.2015.

11. Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.

12. A pilot study of denileukin diftitox (DD) in combination with high-dose interleukin-2 (IL-2) for patients with metastatic renal cell carcinoma (RCC).

13. Effect of sunitinib on renal cell carcinoma cutaneous metastasis.

14. A Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).

15. NCCN clinical practice guidelines in oncology: kidney cancer.

16. Metastatic renal cell carcinoma with partial response to sunitinib complicated by ureteral obstruction from necrotic tumor.

17. Kidney cancer. Clinical practice guidelines in oncology.

19. Implications of therapy choice on overall survival in metastatic renal cell carcinoma: a single institution experience.

20. Kidney cancer. Clinical practice guidelines.

21. A review of recent findings involving interleukin-2-based cancer therapy.

Catalog

Books, media, physical & digital resources